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Abstract Hydropathy analysis of the amino acid sequence of
the Pho84 phosphate permease of Saccharomyces cerevisiae
suggests that the protein consists of 12 transmembrane domains
connected by hydrophilic loops. The Pho84 protein has been
modified by a gene fusion approach, yielding two different N-
terminal His-tagged chimeras which can be expressed in
Escherichia coli, purified and functionally reconstituted into
defined proteoliposomes. The continuous epitopes in the N- and
C-terminal sequences of the Pho84 chimeras were shown to be
accessible in proteoliposomes containing the purified active
Pho84 proteins. Site-specific proteolysis of the immunoreactive
N-terminal sequence in the reconstituted protein suggests a
unidirectional insertion into liposomes.
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1. Introduction
The Pho84 phosphate permease of Saccharomyces cerevi-
siae, encoded by the PHO84 gene [1], belongs to a family of
phosphate:H symporters and is a member of the major fa-
cilitator superfamily [2]. This hydrophobic integral membrane
protein consisting of 587 amino acid residues catalyzes the
coupled transport (symport) of phosphate and H across
the yeast plasma membrane by conversion of the energy
stored in an electrochemical H gradient into energy for
translocation of phosphate into the cell (see [3^5] for reviews).
The synthesis and activity of this transporter are regulated at
the transcriptional level by the PHO regulatory pathway [6,7].
Synthesis and activation of this high-a⁄nity transporter is
strictly regulated and is favored at external phosphate concen-
trations lower than 100 WM. Activation of the Pho84 phos-
phate transport system thus allows the cells to scavenge phos-
phate from the environment under conditions of phosphate
limitation. However, upon exhaustion of external phosphate
to concentrations below 50 WM, de novo synthesis of the
Pho84 protein is halted and high-a⁄nity phosphate transport
across the plasma membrane is abolished by a degradative re-
routing of the protein to the vacuole ([7], Petersson and Pers-
son, unpublished information). Although recent evidence has
been presented that additional gene products such as Pho86
[8], Pho87 [9], Pho88 [10] and Gtr1, a putative GTP-binding
protein [11], act together with the Pho84 permease in a regu-
latory unit, strong evidence that the Pho84 protein contains
the phosphate translocation pathway has been obtained in
intact cells by gene disruption analyses [1,12], in inverted plas-
ma membrane vesicles [13] and, unequivocally, by Escherichia
coli expression of a histidine-tagged Pho84 protein which was
shown to catalyze an uncoupler-sensitive accumulation of
phosphate after puri¢cation and reconstitution [14]. Thus,
proteoliposomes reconstituted with this polypeptide catalyze
the high-a⁄nity phosphate transport observed in intact cells
and inverted plasma membrane vesicles. Accordingly, in the
presence of a proton electrochemical gradient (vp), hydrogen
ions move down their electrochemical gradient, driving up-hill
translocation of phosphate. Based on hydropathy analysis, a
secondary structure model has been proposed (see [5]) in
which the transporter contains 12 transmembrane segments
connected by hydrophilic loops and expanded N- and C-ter-
mini at the same membrane face. In order to characterize the
topology and kinetics of the puri¢ed transporter, an unidirec-
tional reconstitution of the protein into liposomes is desirable.
In the present study, we show that two puri¢ed Pho84 fusion
proteins with highly polar His-tagged peptides of 23 and 33
amino acid residues, respectively, attached to the N-terminus
of Pho84 can be unidirectionally reconstituted into catalyti-
cally active proteoliposomes with their N- and C-termini ex-
posed on the exterior face of the vesicles. Furthermore, inter-
actions between the termini of the reconstituted Pho84 protein
and antibodies directed against these perturb Pho84-catalyzed
phosphate transport.
2. Materials and methods
2.1. Materials
[32P]orthophosphate (carrier free), anti-rabbit Ig donkey antibody-
conjugated horseradish peroxidase (HRP) and an enhanced chemilu-
minescence detection kit were obtained from Amersham Pharmacia
Biotech (Sweden). Rabbit antisera against synthesized peptides corre-
sponding to partial sequences of the N- and C-termini of the Pho84
protein were raised and puri¢ed as described previously [13]. AntiX-
press (Axp) antibodies were obtained from Invitrogen (The Nether-
lands). Alkaline phosphatase-conjugated goat anti-rabbit and anti-
mouse secondary antibodies and CDP-Star chemiluminescent sub-
strate were purchased from Perkin-Elmer (Sweden). Chromatograph-
ically pure phosphatidylcholine (egg), phosphatidylethanolamine
(egg), lysophosphatidylcholine (egg) and phosphatidylserine (bovine
spinal cord) were purchased from Lipid Products (UK). The endopro-
teinase enterokinase (EK) (bovine, light chain) was purchased from
Calbiochem (USA). Bio-Beads (SM-2) were obtained from Bio-Rad
(Sweden).
2.2. Cloning and expression of Pho84 in E. coli
The Pho84 protein was expressed as a histidine-tagged protein in E.
coli BL21(DE3)pLysS cells, carrying the expression plasmid pET16b
(Novagen). The N-terminal His10-tagged fusion protein was detergent-
solubilized and puri¢ed by immobilized Ni2 a⁄nity chromatography
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in the presence of 0.1% Triton X-100 as described previously [14]. In
order to clone and express a histidine-tagged Pho84 protein contain-
ing a unique EK protease cleavage site and an additional antibody
recognition epitope in the sequence connecting the fused domains, the
PHO84 gene was PCR-ampli¢ed from the PET16b construct and was
cloned into a pTrcHisB plasmid (Invitrogen, The Netherlands). The
novel fusion construct encodes a sequence of six consecutive histidine
residues and the amino acid sequence GMASMTGGNNMGR-
DLYDDDDKD harboring an AXp epitope (DLYDDDDK) and an
EK recognition site (DDDDK) at the 5P-end of PHO84, yielding
plasmid pTrcHisB/His6-AXp/EK-PHO84 (Fig. 1). The resulting con-
struct was veri¢ed by DNA sequencing of double-stranded plasmid
DNA using an ABI 377 automated DNA sequencer and the Thermo-
Sequenase dye terminator cycle sequencing kit (Amersham Pharma-
cia). E. coli TOP10 cells (Invitrogen) harboring pTrcHisB/His6-AXp/
EK-PHO84 were grown aerobically in TB medium [15] at 30‡C in the
presence of 100 Wg/ml ampicillin essentially as described for
BL21(DE3)pLysS harboring PET16b/His10-PHO84 [14]. Pho84 ex-
pression was in both cases initiated by addition of 1 mM isopropyl
thio-L-D-galactoside to cell cultures which had reached an A600 of 0.6.
After further growth for 4 h in the case of PET16b/His10-PHO84 and
for 24 h in the case of pTrcHisB/His6-AXp/EK-PHO84, cells were
harvested by centrifugation as described [14].
2.3. Puri¢cation and reconstitution of Pho84 chimeras
Harvested cells were resuspended at a concentration of 10 g wet
weight per 100 ml in 20 mM sodium phosphate, pH 8.0, 0.5 M NaCl,
2 mM imidazole and 2% Triton X-100 and subjected to lysis in the
presence of lysozyme (about 1 mg/g cells) and 1 mM phenylmethyl-
sulfonyl-£uoride followed by pulsed microtip sonic treatment (Bran-
son Soni¢er 250) at a 40% output e⁄ciency until the lysate was ho-
mogeneous and no longer viscous. Both pET16b-expressed His10-
Pho84 and pTrcHisB-expressed His6-AXp/EK-Pho84 were solubilized
from the cytoplasmic membrane of their expression hosts in the pres-
ence of Triton X-100 essentially as described [14]. Detergent-solubi-
lized protein samples were ¢ltered through a 0.45 Wm ¢lter and ap-
plied onto an immobilized Ni2 a⁄nity resin, pre-equilibrated with
20 mM sodium phosphate, pH 8.0, alternatively 20 mM Tris-HCl, pH
8.0, in the presence of 0.5 M NaCl, 2 mM imidazole and 0.2% Triton
X-100, followed by removal of non-bound and loosely bound proteins
by washing with eight bed volumes of equilibration bu¡er and by
eight bed volumes of equilibration bu¡er containing 60 mM imida-
zole, respectively. Fractions eluted in the presence of 120 mM imida-
zole were collected and analyzed by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) followed by protein
detection. Pho84-containing fractions were pooled and subjected to
bu¡er exchange by use of a HiPrep desalting (Amersham Pharmacia)
column. Collected fractions containing puri¢ed Pho84 in 20 mM
Tris-HCl, pH 8.0, 0.2% Triton X-100, 0.2 M NaCl and 10% glycerol
were pooled and reconstituted.
2.4. Reconstitution of Pho84 chimeras
Reconstitution of the puri¢ed His6-AXp/EK-Pho84 and His10-
Pho84 chimeras into liposomes composed of 42.5% phosphatidylcho-
line (PC), 42.5% phosphatidylethanolamine (PE), 10% lysophospha-
tidylcholine (LPC) and 5% phosphatidylserine (PS) (all mass per vol-
ume) was performed essentially as described [14]. The appropriate
amounts of lipids were dried under N2 (g), re-dissolved in diethyl
ether, dried, resuspended to a ¢nal concentration of 20 mg/ml in
25 mM K-N-(2-hydroxyethyl)piperazine-NP-(2-ethanesulfonic acid)
(HEPES), pH 6.6, and sonicated to near clearness with a microtip
sonicator (Branson Soni¢er 250) at a 20% output e⁄ciency. The pu-
ri¢ed His6-AXp/EK-Pho84 and His10-Pho84 contained in elution
bu¡er (20 mM Tris-HCl, pH 8.0, 0.2% Triton X-100, 0.2 M NaCl
and 10% glycerol) was mixed with the liposomes at a protein concen-
tration of 0.15 mg/ml. The protein-lipid mixture was incubated for
30 min at 4‡C, after which the detergent was removed by a sequential
Bio-Beads treatment essentially according to the method of Knol et al.
[16]. Fresh Bio-Beads (80 mg), extensively washed with methanol,
ethanol and ¢nally rinsed in water, were added per ml of liposome
mixture and incubated for 2 h at 4‡C under slow agitation. After
removal of the Bio-Beads by centrifugation, fresh Bio-Beads (150
mg/ml) were added. After an additional 2 h, the beads were removed
and the procedure was repeated with a 12 h treatment. Following
removal of the Bio-Beads, the proteoliposomes were collected by cen-
trifugation at 133 500Ug for 1 h and resuspended in 25 mM K-
HEPES, pH 6.6, at a lipid concentration of 20 mg/ml, frozen in liquid
N2 and stored at 380‡C. Preparation of liposomes devoid of protein
was accomplished essentially as described above except that protein
and Triton X-100 additions were excluded.
2.5. Transport measurements with proteoliposomes
Phosphate uptake was measured in proteoliposomes containing
His10-Pho84 and His6-AXp/EK-Pho84. Proteoliposomes (1 Wl)
pre-loaded with 25 mM K-HEPES, pH 6.6, were diluted 200-fold
in 25 mM Tris-succinate, pH 4.5, containing 0.11 mM
[32P]orthophosphate (0.18 Ci/Wmol; 1 mCi = 37 MBq) to generate a
vp (interior alkaline). The suspension was immediately blended in a
vortex mixer and incubated at 25‡C. Transport assays were termi-
nated at a given time by quenching of the reaction with 2 ml ice-
cold dilution bu¡er (25 mM Tris-succinate, pH 4.5) containing
150 mM LiCl and immediate ¢ltration using Supor-200 ¢lters
(0.2 mm pore size, Pall-Gelman Sciences). Filters were washed with
an additional 2 ml of the quench bu¡er and radioactivity retained on
the ¢lters was determined by liquid scintillation spectrometry.
2.6. Proteolytic cleavage
Puri¢ed, detergent-solubilized protein (10 Wg) and proteoliposomes
containing the reconstituted His6-AXp/EK-Pho84 chimera (10 Wg)
were incubated with 0.2 U EK for 5 h at 37‡C followed by 16 h at
room temperature, in the presence of 50 mM Tris-HCl, pH 8.0, and
1 mM CaCl2. The liposomes were washed two times with 1 ml 25 mM
K-HEPES, pH 6.6, pelleted by centrifugation at 247 000Ug for
30 min and resuspended in 50 Wl of the same bu¡er. Subsequently,
liposomes were solubilized in 1.3% SDS and immediately subjected to
SDS-PAGE followed by Western blotting. Immunodetection was ac-
complished with AXp antibody.
2.7. Analytical methods
SDS-PAGE was performed using a 12% polyacrylamide and bispo-
lyacrylamide gel system [17]. Gels were stained with GelCode Blue
Stain Reagent (Pierce). Speci¢c detection of detergent-solubilized
and reconstituted Pho84 chimeras was achieved by Western blot anal-
ysis using puri¢ed Pho84 anti-(C-terminal peptide) and anti-(N-termi-
nal peptide) antibody and anti-rabbit Ig donkey antibody-conjugated
HRP or AXp antibody and goat-anti mouse secondary antibody con-
jugated to alkaline phosphatase. After a short incubation with chem-
iluminescent substrate, the blot was exposed to ¢lm for 1^2 min. The
molecular mass of separated proteins was determined by the relative
mobilities of the pre-stained marker proteins (Bio-Rad). Protein de-
termination was performed by use of the commercially available Bio-
Rad DC Protein Assay kit (Bio-Rad). Bovine serum albumin was used
as standard.
3. Results
3.1. Properties of constructed Pho84 chimeras
We have previously shown that a constructed histidine-
tagged version of the H-coupled Pho84 phosphate permease
of S. cerevisiae can be expressed in the cytoplasmic membrane
of E. coli and that immobilized Ni2 a⁄nity chromatography
of the Triton X-100-solubilized His10-Pho84 chimera allows
for an e⁄cient puri¢cation of the protein [14]. Although the
puri¢ed His10-Pho84 catalyzes a high-a⁄nity uncoupler-sensi-
tive uptake of phosphate when reconstituted in proteolipo-
somes with a de¢ned phospholipid composition [14], it was
desirable to construct an alternative histidine-tagged Pho84
protein in order to facilitate immunological studies of the
reconstituted chimera. The novel His6-Pho84 protein contains
an AXp antibody epitope and a partially overlapping EK
recognition site in the sequence connecting the His6 sequence
to the N-terminus of the Pho84 protein (Fig. 1). The His6-
AXp/EK-Pho84 protein can, like the His10-Pho84 protein, be
expressed in the cytoplasmic membrane of E. coli, solubilized
with Triton X-100, puri¢ed by immobilized Ni2 a⁄nity chro-
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matography and reconstituted into proteoliposomes. As
shown in Fig. 2, the puri¢ed protein in the detergent-solubi-
lized state and in proteoliposomes could be detected as a
single band with an apparent molecular mass of about 75
kDa by staining and by immunodetection of the epitopes
contained within the Pho84 protein by use of anti-(N-terminal
peptide) and anti-(C-terminal peptide) antibodies and by the
AXp epitope in the His6-AXp/EK-Pho84 protein.
3.2. Activity of Pho84 in proteoliposomes
The Triton X-100-solubilized, puri¢ed His6-AXp/EK-Pho84
protein was reconstituted into de¢ned proteoliposomes com-
posed of PC/PE/PS/LPC. The H-coupled symport activity of
reconstituted His6-AXp/EK-Pho84 protein was investigated
by measuring 32P accumulation in proteoliposomes loaded
with 25 mM K-HEPES, pH 6.6. A vp (interior alkaline
and negative) was imposed across the proteoliposomal mem-
brane by a 200-fold dilution of the proteoliposomes into a
bu¡er with pH 4.5. In Fig. 3, it is shown that vp-driven
uptake of phosphate occurs at an initial rate of 0.3 Wmol/
min/mg protein. In the presence of the protonophore carbon-
ylcyanide m-chlorophenylhydrazone (CCCP), phosphate accu-
mulation was almost completely inhibited after an initial rapid
rate of uptake of 0.3 Wmol phosphate/mg during the ¢rst min
of the reaction. As the His6-AXp/EK-Pho84 fusion protein is
functionally competent when reconstituted into proteolipo-
somes, it is clear that the N-terminal sequence attachment
does not lead to inactivation of the transport function. How-
ever, in an experiment where the anti-(N-terminal peptide)
and anti-(C-terminal peptide) antibodies were incubated with
proteoliposomes harboring the puri¢ed His10-Pho84 protein,
the rate of vp-driven phosphate accumulation was inhibited
by 50% in the presence of the anti-(N-terminal peptide) anti-
body and by 75% in the presence of anti-(C-terminal peptide)
antibodies (Fig. 4). In contrast, treatment of the proteolipo-
somes with an antibody directed against the PMA1 H-ATP-
ase of S. cerevisiae did not a¡ect the transport activity of the
Pho84 protein.
3.3. Orientation of Pho84 in proteoliposomes
In order to investigate whether the degree of inhibition of
vp-driven phosphate accumulation observed when the proteo-
liposomes harboring the Pho84 protein were treated with anti-
Fig. 1. Schematic secondary structure model of the Pho84 chimeras.
The model is based on hydropathy analysis of the deduced Pho84
amino acid sequence [1]. Putative transmembrane segments are
shown as boxes. The N- and C-terminal regions of the transporter
corresponding to the epitopes recognized by the anti-(N-terminal
peptide) antibody and anti-(C-terminal peptide) antibody, the Axp
antibody recognition sites in the histidine-Pho84 chimera are indi-
cated by underlined one-letter amino acid codes.
Fig. 2. SDS-PAGE of puri¢ed and reconstituted His6-AXp/EK-
Pho84 in proteoliposomes. The presence of puri¢ed His6-AXp/EK-
Pho84 protein (2 Wg) in proteoliposomes was visualized by 12%
PAGE followed by protein staining (lane 1). The immunoreactivity
of puri¢ed Triton X-100-solubilized (1.5 Wg) and reconstituted (4
Wg) His6-AXp/EK-Pho84 protein was analyzed by Western blot
analysis with anti-(N-terminal peptide) antibody (lane 2 and 3, re-
spectively), anti-(C-terminal peptide) antibody (lane 4 and 5, respec-
tively) and AXp antibody (lane 6 and 7, respectively). The protein
in proteoliposomes was solubilized with 1.3% SDS and subjected to
SDS-PAGE.
Fig. 3. Uncoupler-sensitive phosphate transport catalyzed by His6-
AXp/EK-Pho84 in proteoliposomes. Proteoliposomes containing 0.1
mg puri¢ed His6-AXp/EK-Pho84/ml were assayed for phosphate up-
take as described in Section 2 in the absence (l) and in the presence
(n) of 20 WM CCCP. At given times, transport was stopped and the
samples were assayed by rapid ¢ltration and liquid scintillation
spectrometry.
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(N-terminal peptide) and anti-(C-terminal peptide) antibodies
was due to a mixed orientation of the reconstituted protein,
the N-terminal region of the His6-AXp/EK-Pho84 was se-
lected for determination of the orientation of the reconstituted
protein in proteoliposomes. In this analysis, the partially over-
lapping AXp epitope and EK recognition site were used for
site-speci¢c proteolysis and immunodetection. Proteolipo-
somes harboring the puri¢ed His6-AXp/EK-Pho84 subjected
to treatment with EK were analyzed by SDS-PAGE and the
AXp/EK epitope was detected by Axp antibody. As shown in
Fig. 5, where the accessibility of the AXp epitope was moni-
tored after proteolytic treatment, the proteolytic site was
highly accessible as the enzyme cleaved reconstituted His6-
AXp/EK-Pho84 to the same extent as the detergent-solubi-
lized non-reconstituted protein. The obtained results clearly
indicate a unidirectional orientation of the Triton X-100-re-
constituted protein in the PC/PE/PS/LPC proteoliposomes
where the N- and C-termini are outwardly exposed.
4. Discussion
Support for a secondary structure model of the polytopic
Pho84 transporter in which the 12 transmembrane segments
traverse the membrane in a zigzag fashion has been obtained
by hydropathy pro¢le analysis of the amino acid sequence (see
[5]). In this paper, we describe experimental evidence for the
topological arrangement of this transporter by applying a
gene fusion approach together with analysis of the transport
activity, accessibility of immunoreactive domains and site-spe-
ci¢c proteolysis. The results obtained describe the oriented
functional reconstitution of two Pho84 chimeras, His10-
Pho84 and His6-AXp/EK-Pho84, into proteoliposomes with
a de¢ned lipid composition. Both chimeras were expressed
in E. coli, puri¢ed by immobilized Ni2 a⁄nity chromatogra-
phy in the presence of Triton X-100. As judged by a compar-
ison between the two Pho84 chimeras, the attachment of 23 or
33 additional residues harboring the His10 and the His6-AXp/
EK sequences to the N-terminus, both constructions yielded a
functional Pho84 protein, suggesting that at least the N-ter-
minus of the protein can be modi¢ed without a major in£u-
ence on the activity. However, immunodecoration of N-termi-
nal or C-terminal sequences in the reconstituted protein
results in a partial loss of phosphate transport activity. The
di¡erences in transport activities observed with the anti-(N-
terminal peptide) and anti-(C-terminal peptide) antibodies
cannot be attributed to an e¡ect of transporter orientation.
Rather, the lowered transport rate observed with the anti-(C-
terminal peptide) antibody-treated Pho84 protein as compared
to that of the anti-(N-terminal peptide) antibody might be
explained by a previously proposed weaker antigenicity of
the N-terminal domain in the fusion protein (see Fig. 1) as
compared to the wild-type Pho84 protein [14] and/or a higher
sensitivity in the protein towards a modi¢cation of the
C-terminal.
As the Pho84 protein previously has been shown to catalyze
phosphate uptake in tightly sealed isolated inverted plasma
membrane vesicles of S. cerevisiae cells expressing the Pho84
protein [13], the direction of phosphate transport catalyzed by
the Pho84 protein seems to be determined by the direction of
the driving force, as for many other secondary transport sys-
Fig. 4. Antibody-speci¢c inhibition of phosphate uptake in proteoli-
posomes containing puri¢ed His10-Pho84 protein. Proteoliposomes
containing puri¢ed reconstituted His10-Pho84 protein at a protein
and lipid concentration of 0.1 and 11 mg/ml, respectively, were in-
cubated in the absence (m) or in the presence of a⁄nity-puri¢ed
anti-(N-terminal peptide) antibody (o), in the presence of a⁄nity-pu-
ri¢ed anti-(C-terminal peptide) antibody (s) and in the presence of
an antibody directed against the PMA H-ATPase of S. cerevisiae
(l) for 10 min at 25‡C at a molar ratio of 1:1 with respect to the
Pho84 protein. Aliquots (1 Wl) of the incubated proteoliposomes
were assayed for phosphate uptake as described in Section 2.
Fig. 5. Proteolytic cleavage of Triton X-100-solubilized and reconsti-
tuted His6-AXp/EK-Pho84. Aliquots (30 Wl) of detergent-solubilized
His6-AXp/EK-Pho84 protein (lanes 1 and 2, 1 Wg) and proteolipo-
somes containing reconstituted His6-AXp/EK-Pho84 protein (lanes
3 and 4, 2 Wg) were incubated in the absence (lanes 1 and 3) or in
the presence (lanes 2 and 4) of EK as described in Section 2 and
were analyzed by SDS-PAGE followed by Western blot analysis.
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tems which operates bidirectionally, rather than by the orien-
tation of the protein in the membrane.
The partial inactivation of the Pho84 transporter does not
re£ect a bidirectional topological arrangement of the recon-
stituted protein as proteolytic cleavage of the N-terminus of
the His6-AXp/EK-Pho84 chimera resulted in no detectable
Pho84 signal when EK-treated proteoliposomes were solubi-
lized and analyzed by SDS-PAGE/Western blot analysis. The
unidirectional liposomal insertion of membrane proteins such
as the Pho84 permease, of which the inner and outer surface
di¡er in hydrophilicity, is possible due to the lower tendency
of large hydrophilic domains to traverse the lipid bilayer once
closed liposomal structures have been formed as a conse-
quence of detergent-binding to the polystyrene Bio-Beads.
The obtained results suggest that the Pho84 permease, in anal-
ogy with LacS lactose permease of Streptococcus thermophilus
[18] and the PutP proline transporter of E. coli [19] reconsti-
tuted in the presence of Triton X-100 followed by detergent
removal by Bio-Beads, is unidirectionally incorporated into
the liposomes with its N- and C-termini and large central
hydrophilic loop protruding towards the exterior.
Taken together, the results shown in this work with puri¢ed
histidine-tagged Pho84 chimeras provide the ¢rst experimental
evidence for a functional unidirectional orientation of the
Pho84 transporter reconstituted into proteoliposomes with
its termini protruding towards the exterior. Although the pro-
tein is able to catalyze a bidirectional transport of phosphate,
the establishment of the orientation of the reconstituted trans-
porter in proteoliposomes is critical as it can be expected that
the kinetics of transport di¡er depending on the direction of
transport.
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